Ventana Medical Systems
Katherine Leith is a seasoned professional in quantitative development and biostatistics with extensive experience in both academic and industry settings. As a Principal Quantitative Development Scientist at Roche since February 2012, Katherine leads teams in applying advanced quantitative methods and innovating solutions to industry challenges. Katherine's prior roles include Principal Biostatistician, Senior Biostatistician, and Biostatistician at Clemson University from May 2009 to 2014, where work focused on statistical analysis across various fields, and an Adjunct Faculty position at Pima Community College, teaching College Algebra with Data Analysis. Katherine holds a Ph.D. in Applied Statistical Analysis and Wildlife and Fisheries Biology, an M.S. in Applied Statistics, and a B.A. in Psychology with a minor in Applied Ethics, all from Clemson University and Northern Michigan University.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.